Internal Medicine, Pulmonary Disease · Altoona, PA
NPI
1487787131
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Chestnut Ave
Altoona, PA, 16601
Phone (814) 946-2845
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
2,418 services
Medicare patients, 2024
554
Average age 75
Drug cost, 2024
$2.4M
3,783 prescriptions
Company payments, 2025
$193K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan J Kanouff was code 99233 (hospital e&m - subsequent), 1,178 times for 220 patients. In total Alan J Kanouff billed 2,418 services in 34 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,178 | 220 | $89.30 | $105K |
| 99214 Office E&M - Established | Office | 452 | 287 | $85.05 | $38K |
| 94010 Pulmonary Function Testing | Office | 178 | 138 | $17.49 | $3,114 |
| 99222 Hospital E&M - Initial | Facility | 68 | 63 | $98.54 | $6,701 |
| 99204 Office E&M - New | Office | 61 | 61 | $109.89 | $6,704 |
| 99223 Hospital E&M - Initial | Facility | 59 | 59 | $130.49 | $7,699 |
| 71046 X-ray - Chest | Office | 53 | 45 | $21.94 | $1,163 |
| 96160 E&M - Miscellaneous | Office | 33 | 28 | $1.72 | $56.64 |
| 94729 Pulmonary Function Testing | Office | 29 | 29 | $40.16 | $1,165 |
| 94060 Pulmonary Function Testing | Office | 29 | 29 | $26.72 | $775 |
| 94727 Pulmonary Function Testing | Office | 28 | 28 | $32.76 | $917 |
| 99213 Office E&M - Established | Office | 25 | 19 | $47.32 | $1,183 |
| 95811 Sleep Study | Office | 16 | 15 | $451.45 | $7,223 |
| 94681 Pulmonary Function Testing | Office | 15 | 12 | $32.72 | $491 |
| 95810 Sleep Study | Office | 13 | 13 | $397.51 | $5,168 |
By year: 2022 $113K for 1,638 services; 2023 $219K for 3,020 services; 2024 $191K for 2,418 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan J Kanouff prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 850 prescriptions and refills. In total Alan J Kanouff wrote 3,783 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 850 | 1,050 | 145 | $647K |
| Montelukast Sodium Generic | 315 | 521 | 54 | $3,953 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 249 | 284 | 73 | $8,437 |
| Roflumilast Generic | 206 | 302 | 40 | $19K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 181 | 241 | 40 | $145K |
| Azithromycin Generic | 151 | 190 | 24 | $1,191 |
| Fluticasone Propionate Generic | 124 | 161 | 32 | $1,269 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 106 | 130 | 19 | $17K |
| Prednisone Generic | 104 | 137 | 52 | $520 |
| Breo Ellipta Fluticasone/Vilanterol | 101 | 127 | 23 | $49K |
| Ventolin Hfa Albuterol Sulfate | 65 | 73 | 16 | $4,595 |
| Eszopiclone Generic | 58 | 58 | 12 | $921 |
| Zolpidem Tartrate Generic | 56 | 58 | Under 11 | $288 |
| Tezspire Tezepelumab-Ekko | 54 | 54 | Under 11 | $243K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 52 | 78 | Under 11 | $578 |
Brand drugs: 2,006 claims; generic drugs: 1,777 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan J Kanouff $193K ($193K in general payments such as food, travel and fees) from 31 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $151K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 210 | $151K |
| Verona Pharma, Inc. VRNA | 30 | $19K |
| Axsome Therapeutics, Inc. AXSM | 19 | $12K |
| Genentech USA, Inc. ROG.SW | 12 | $5,034 |
| GlaxoSmithKline, LLC. GSK | 19 | $4,104 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $265 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $205 |
| Resmed Corp RMD | 2 | $157 |
| Insmed, Inc. INSM | 14 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.